191 related articles for article (PubMed ID: 13822061)
1. [Apropos of the meprobamate-reserpine combination. New indications apropos of a series of 350 cases].
FELDMANN H
Praxis; 1959 Dec; 48():1185-7. PubMed ID: 13822061
[No Abstract] [Full Text] [Related]
2. [A new trial of meprobamate: the injectable form in hospital therapy].
BROUSSOLLE P; ROSIER Y
Ann Med Psychol (Paris); 1962 Jan; 120(1)():130-8. PubMed ID: 13873549
[No Abstract] [Full Text] [Related]
3. Further controlled studies of meprobamate.
BULLA JD; EWING JA; BUFFALOE WJ
Am Pract Dig Treat; 1959 Nov; 10():1961-4. PubMed ID: 13805867
[No Abstract] [Full Text] [Related]
4. [Contribution to the clinical testing of meprobamate in injectable form].
DUBOIS ; ROGE
Rev Int Serv Sante Armees; 1959 Nov; 32():629-32. PubMed ID: 13849647
[No Abstract] [Full Text] [Related]
5. Clinical experience with a meprobamatepromazine combination in psychiatric practice.
ROBERTSON RB
Dis Nerv Syst; 1960 Mar; 21():165-8. PubMed ID: 14437879
[No Abstract] [Full Text] [Related]
6. Prozine therapy in emotionally disturbed patients.
CARTER CH
Dis Nerv Syst; 1960 May; 21():278-81. PubMed ID: 13808023
[No Abstract] [Full Text] [Related]
7. [Intraspinal reserpine in neuropsychiatry].
BRAGE D
Prensa Med Argent; 1959 Apr; 46():923-8. PubMed ID: 13803762
[No Abstract] [Full Text] [Related]
8. [Results of clinical studies on Meprotan].
KORKINA MV; NARODITSKAIA VF; STREL'TSOVA ZG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():886-9. PubMed ID: 13753172
[No Abstract] [Full Text] [Related]
9. [Clinical experience with the preparation, Faseina (combination of reserpine and orphenadrine)].
MASCELLANI A
Arcisp S Anna Ferrara; 1960; 13():1023-31. PubMed ID: 13767717
[No Abstract] [Full Text] [Related]
10. [The use of the reserpine-orphenadrine association in liquid vehicle in psychiatric treatment].
CATAGNI F
Rass Studi Psichiatr; 1960; 49():250-2. PubMed ID: 13808364
[No Abstract] [Full Text] [Related]
11. A combination sedative in emotionally disturbed office patients.
KOLODNY AL; FULLER HL
Dis Nerv Syst; 1960 Apr; 21():220-5. PubMed ID: 14410752
[No Abstract] [Full Text] [Related]
12. Five-year follow-up of results of reserpine therapy in mental hospital practice.
MAGGS R; ELLISON RM
J Ment Sci; 1960 Apr; 106():590-8. PubMed ID: 14419846
[No Abstract] [Full Text] [Related]
13. A pilot trial of orphenadrine ("disipal") in patients treated with reserpine.
LANGLEY GE; ROBIN AA
J Ment Sci; 1960 Apr; 106():682-5. PubMed ID: 14413993
[No Abstract] [Full Text] [Related]
14. A comparative clinical study of meprobamate and chlordiazepoxide.
PENNINGTON VM
Med Times; 1962 Aug; 90():841-6. PubMed ID: 14485129
[No Abstract] [Full Text] [Related]
15. [A follow-up of patients treated with reserpine].
GRAVEM A; JORSTAD J; STANG J
Tidsskr Nor Laegeforen; 1960 May; 80():438-41. PubMed ID: 13829072
[No Abstract] [Full Text] [Related]
16. Reserpine and methylphenidylacetate effects on socialization and activity.
NISWANDER GD; HASLERUD GM; BRODY N; CASEY TM
J Nerv Ment Dis; 1957; 125(1):51-6. PubMed ID: 13481697
[No Abstract] [Full Text] [Related]
17. [Trial therapy of reserpine in hospitals treating patients with mental disorders; 80 cases].
MAUREL H; WILHELM ; SPIELMANN JP
Concours Med; 1955 Sep; 77(37):3351-5. PubMed ID: 13261532
[No Abstract] [Full Text] [Related]
18. The clinical use of reserpine in mental cases.
BROOKS C
J Med Assoc State Ala; 1956 Jul; 26(1):9-11. PubMed ID: 13346277
[No Abstract] [Full Text] [Related]
19. Promazine hydrochloride and combined promazine hydrochloride-meprobamate treatment of hospitalized psychotic patients.
VLAVIANOS G; FINK L
Dis Nerv Syst; 1960 Sep; 21():515-7. PubMed ID: 13781745
[No Abstract] [Full Text] [Related]
20. [Reserpine therapy of mental disorders. II].
VOELKEL A
Dtsch Med J; 1956 Feb; 7(3-4):72-4. PubMed ID: 13317710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
